Cargando…
Differentiation Therapy of Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a predominant acute leukemia among adults, characterized by accumulation of malignantly transformed immature myeloid precursors. A very attractive way to treat myeloid leukemia, which is now called ‘differentiation therapy’, was proposed as in vitro studies have shown...
Autores principales: | Gocek, Elzbieta, Marcinkowska, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757424/ https://www.ncbi.nlm.nih.gov/pubmed/24212816 http://dx.doi.org/10.3390/cancers3022402 |
Ejemplares similares
-
NADPH-Cytochrome P450 Reductase Is Regulated by All-Trans Retinoic Acid and by 1,25-Dihydroxyvitamin D(3) in Human Acute Myeloid Leukemia Cells
por: Gocek, Elżbieta, et al.
Publicado: (2014) -
The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia Therapy
por: Gocek, Elzbieta, et al.
Publicado: (2015) -
Regulation of Leukemic Cell Differentiation through the Vitamin D Receptor at the Levels of Intracellular Signal Transduction, Gene Transcription, and Protein Trafficking and Stability
por: Gocek, Elżbieta, et al.
Publicado: (2012) -
Vitamin D Derivatives in Acute Myeloid Leukemia: The Matter of Selecting the Right Targets
por: Marcinkowska, Ewa
Publicado: (2022) -
Differentiation and Cell Survival of Myeloid Leukemia Cells
por: Studzinski, George P., et al.
Publicado: (2012)